VivoSeq
Other

Closed-Loop

0

Pipeline Programs↗

5

Active Trials↗

0

Companies Involved↗

Closed-Loop is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

86/100

Attrition Rate

10/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

21

clinical trials

Completed12 · 57%
Recruiting3 · 14%
Unknown status2 · 10%
Terminated2 · 10%
Not yet recruiting2 · 10%

Clinical Trials

Trial Activity

21 trials

Extended Bolus for Meals in a Closed-loop System
Recruiting·UUniversity of California, San Francisco·Phase 4·NCT05454891·30 enrolled
Performance Analysis of Hermetic Closed-loop Anesthesia Delivery System
Recruiting·SSir Ganga Ram Hospital·N/A·NCT05967403·150 enrolled
Modeling and Closed-loop Control of Depth of Anaesthesia
Recruiting·UUniversity of Ljubljana·N/A·NCT03569839·50 enrolled
Feasibility of Closed-loop TCI Based on New EEG Baseline in the Presence of Low Dose of Esketamine
Not yet recruiting·—·Phase 4·NCT06729892·120 enrolled
Closed-loop Non-invasive Stimulation for Improving Brain and Mental Health in Healthy Individuals
Not yet recruiting·UUniversity of Nottingham·Preclinical·NCT07671079·30 enrolled
Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation
Completed·IInstitut de Recherches Cliniques de Montreal·Phase 2·NCT02626936·10 enrolled
Closed-loop Control of Penicillin Delivery
Completed·IImperial College London·Phase 1·NCT04053140·6 enrolled
Perioperative Closed-loop Glucose Control
Completed·IInsel Gruppe AG, University Hospital Bern·N/A·NCT04361799·45 enrolled
Lidocaine and Closed-Loop Anesthesia System
Completed·HHopital Foch·Phase 3·NCT01154738·82 enrolled
Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2
Completed·IInstitut de Recherches Cliniques de Montreal·Phase 2·NCT02798250·11 enrolled
Improving Post-Prandial Blood Glucose Control With Afrezza During Closed-Loop Therapy
Completed·YYale University·Phase 1·NCT03234491·15 enrolled
Insulin-plus-pramlintide Closed-loop Strategy to Regulate Glucose Levels Without Carbohydrate Counting
Completed·MMcGill University·Phase 2·NCT03800875·24 enrolled
Evaluation of Fiasp® (Fast Acting Insulin Aspart) in 670G Hybrid Closed-Loop Therapy
Completed·SStanford University·Phase 4·NCT03554486·27 enrolled
Evaluation of a Closed-Loop Control System for Administering Patient-Specific Anesthesia
Completed·SStanford University·Phase 1·NCT00683956·35 enrolled
Fast Advanced Closed-Loop Therapy
Completed·UUniversity of Ljubljana, Faculty of Medicine·N/A·NCT04853030·30 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)